Optimal Control of Liver Metastases From Colorectal Cancer With Cetuximab and Hepatic Artery Infusion of Chemotherapy

Mise à jour : Il y a 4 ans
Référence : NCT00852228

Femme et Homme

Extrait

The primary objective of the study is to increase by 15% the complete macroscopic resection rate of predominantly liver metastases from metastatic colorectal cancer through combining systemic cetuximab and hepatic artery infusion of three-drug chemotherapy (irinotecan, oxaliplatin and 5-fluorouracil).


Critère d'inclusion

  • Metastatic colorectal cancer ,Liver Metastases ,Hepatic Lesions


Liens